Glucotrack

Glucotrack company information, Employees & Contact Information

Explore related pages

Related company profiles:

At Glucotrack, we are pioneers in diabetes technology, dedicated to transforming the way diabetes is managed. Our mission is to develop innovative, long-term solutions that prioritize accuracy and ease of use. With a commitment to reducing the daily burden of diabetes management, we create cutting-edge technologies designed to enhance the lives of those we serve. Join us in our journey towards a future where managing diabetes is simpler, more effective, and empowering.

Company Details

Employees
15
Address
Rutherford, Nj 07070, Us
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
Keywords
IT Consulting.
HQ
Rutherford, NJ
Looking for a particular Glucotrack employee's phone or email?

Glucotrack Questions

News

Glucotrack, Inc. Reminds Shareholders to Vote - Yahoo Finance

Glucotrack, Inc. Reminds Shareholders to Vote Yahoo Finance

Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement - Stock Titan

Glucotrack (NASDAQ: GCTK) sets Oct 31 special meeting on Equity Purchase Agreement Stock Titan

Glucotrack, Inc. Successfully Repurchases Over 90% of Series A Warrants as Part of Capital Formation Strategy - Quiver Quantitative

Glucotrack, Inc. Successfully Repurchases Over 90% of Series A Warrants as Part of Capital Formation Strategy Quiver Quantitative

Glucotrack, Inc. Advances Continuous Blood Glucose Monitoring Technology with Clinical Study Initiation in Australia by Q3 2025 - Nasdaq

Glucotrack, Inc. Advances Continuous Blood Glucose Monitoring Technology with Clinical Study Initiation in Australia by Q3 2025 Nasdaq

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor - GlobeNewswire

Glucotrack and OneTwo Analytics to Collaborate for Clinical Study Analysis on Its Continuous Blood Glucose Monitor GlobeNewswire

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - Yahoo Finance

Glucotrack to Showcase Long-Term Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions Yahoo Finance

Diabetes Tech Company Glucotrack to Present Latest Developments at Q3 Virtual Investor Summit - Stock Titan

Diabetes Tech Company Glucotrack to Present Latest Developments at Q3 Virtual Investor Summit Stock Titan

Glucotrack Announces Repurchase of Series A Warrants - Yahoo Finance

Glucotrack Announces Repurchase of Series A Warrants Yahoo Finance

Revolutionary Blood Glucose Monitor Outperforms Traditional CGMs with 7.7% Accuracy in Landmark Trial - Stock Titan

Revolutionary Blood Glucose Monitor Outperforms Traditional CGMs with 7.7% Accuracy in Landmark Trial Stock Titan

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions - Yahoo Finance

Glucotrack and OneTwo Analytics Present Positive Final Results of First-In-Human Study for Continuous Blood Glucose Monitor at American Diabetes Association’s 85th Scientific Sessions Yahoo Finance

Diabetes Tech Company Glucotrack Eliminates Major Dilution Risk with Strategic 90% Warrant Repurchase - Stock Titan

Diabetes Tech Company Glucotrack Eliminates Major Dilution Risk with Strategic 90% Warrant Repurchase Stock Titan

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor - Yahoo Finance

Glucotrack Announces Ethical Approval for Long-Term Clinical Study of Continuous Blood Glucose Monitor Yahoo Finance

Breakthrough: Glucotrack's Implantable Diabetes Monitor Hits Clinical Milestone, FDA Decision Expected Q4 - Stock Titan

Breakthrough: Glucotrack's Implantable Diabetes Monitor Hits Clinical Milestone, FDA Decision Expected Q4 Stock Titan

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas - Yahoo Finance

Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas Yahoo Finance

Glucotrack Implements Major 1-for-60 Reverse Split: What This Means for Your Investment - Stock Titan

Glucotrack Implements Major 1-for-60 Reverse Split: What This Means for Your Investment Stock Titan

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor - Yahoo Finance

Glucotrack Announces Successful Completion of Its First Human Clinical Study of Continuous Blood Glucose Monitor Yahoo Finance

Glucotrack to Present at TechBio Showcase™ 2025 - Yahoo Finance

Glucotrack to Present at TechBio Showcase™ 2025 Yahoo Finance

Glucotrack Announces Reverse Stock Split - Yahoo Finance

Glucotrack Announces Reverse Stock Split Yahoo Finance

Glucotrack Appoints Peter C. Wulff as CFO - citybiz

Glucotrack Appoints Peter C. Wulff as CFO citybiz

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP To Medical Advisory Board - citybiz

Glucotrack Appoints Guillermo Umpierrez, MD, CDCES, FACE, MACP To Medical Advisory Board citybiz

Glucotrack's Strategic Move: 1-for-20 Reverse Split Could Save Nasdaq Listing - Stock Titan

Glucotrack's Strategic Move: 1-for-20 Reverse Split Could Save Nasdaq Listing Stock Titan

A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology - Drug Delivery Business

A new way to monitor glucose: Glucotrack explains 3-year CBGM implant technology Drug Delivery Business

Glucotrack first-in-human study of long-term CBGM implant meets endpoints - Drug Delivery Business

Glucotrack first-in-human study of long-term CBGM implant meets endpoints Drug Delivery Business

Glucotrack to submit long-term CGM implant for FDA IDE this year - Drug Delivery Business

Glucotrack to submit long-term CGM implant for FDA IDE this year Drug Delivery Business

Glucotrack Begins Enrollment for Long-term Implantable CGM Study - Medical Device and Diagnostic industry

Glucotrack Begins Enrollment for Long-term Implantable CGM Study Medical Device and Diagnostic industry

Glucotrack to submit long-term CGM implant for FDA IDE this year - MassDevice

Glucotrack to submit long-term CGM implant for FDA IDE this year MassDevice

Glucotrack hits trial success for direct blood measuring CGM - Medical Device Network

Glucotrack hits trial success for direct blood measuring CGM Medical Device Network

Glucotrack survey highlights interest in 3-year CBGM - Drug Delivery Business

Glucotrack survey highlights interest in 3-year CBGM Drug Delivery Business

GlucoTrack eyes human trials for implantable blood glucose monitor - Clinical Trials Arena

GlucoTrack eyes human trials for implantable blood glucose monitor Clinical Trials Arena

GlucoTrack stock tumbles after issuing $3.6M convertible note - Investing.com

GlucoTrack stock tumbles after issuing $3.6M convertible note Investing.com

GlucoTrack Stock Soars on Sixth Borough Capital Fund Investment Commitment - StocksToTrade

GlucoTrack Stock Soars on Sixth Borough Capital Fund Investment Commitment StocksToTrade

GlucoTrack’s Surprising Stock Jump: What’s Driving It? - StocksToTrade

GlucoTrack’s Surprising Stock Jump: What’s Driving It? StocksToTrade

GlucoTrack Shares Soar on Sixth Borough Capital Investment Surge​ - StocksToTrade

GlucoTrack Shares Soar on Sixth Borough Capital Investment Surge​ StocksToTrade

GlucoTrack Secures $3.6M Convertible Promissory Note - TipRanks

GlucoTrack Secures $3.6M Convertible Promissory Note TipRanks

Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Update - Stocktwits

Glucotrack Stock Just Rose Over 123% Today: Here’s An Important Update Stocktwits

Implantable CGM maker GlucoTrack names new VP of marketing - Drug Delivery Business

Implantable CGM maker GlucoTrack names new VP of marketing Drug Delivery Business

Why Is GlucoTrack (GCTK) Stock Down 36% Today? - InvestorPlace

Why Is GlucoTrack (GCTK) Stock Down 36% Today? InvestorPlace

GCTK Stock Price and Chart — NASDAQ:GCTK - TradingView

GCTK Stock Price and Chart — NASDAQ:GCTK TradingView

Top Glucotrack Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant